Propionic acids

Dr. Reddy’s Announces the Re-Launch of Over-the-Counter Naproxen Sodium Tablets USP, 220 mg, Store-Brand Equivalent of Aleve® in the U.S. Market

Retrieved on: 
Tuesday, August 3, 2021

The re-launch of Dr. Reddys Naproxen Sodium Tablets, 220 mg (OTC), is an important addition to our Pain/Analgesics portfolio of OTC products, says Marc Kikuchi, CEO, North America Generics, Dr. Reddys Laboratories.

Key Points: 
  • The re-launch of Dr. Reddys Naproxen Sodium Tablets, 220 mg (OTC), is an important addition to our Pain/Analgesics portfolio of OTC products, says Marc Kikuchi, CEO, North America Generics, Dr. Reddys Laboratories.
  • Dr. Reddys OTC Naproxen Sodium Tablets USP, 220 mg is an over-the-counter nonsteroidal anti-inflammatory drug (NSAID) for use as a pain reliever and fever reducer.
  • Dr. Reddys Naproxen Sodium Tablets USP, 220 mg, will be available in multiple-pack sizes to allow consumers a variety of purchasing options.
  • Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.

Lactic Acid Market and Polylactic Acid Markets - Global Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 6, 2021

The "Lactic Acid Market - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Lactic Acid Market - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • By lactic acid application, the biodegradable polymers segment is estimated to be the largest segment during the forecast period.
  • The growth of the market for industrial applications of lactic acid is primarily driven by its use in biodegradable polymers.
  • By form, liquid segment in the lactic acid market estimated to account for the largest share during the forecast period.

New Study Concludes No Correlation Between NSAIDs -- Including Ibuprofen -- and Worsening COVID-19 Outcomes

Retrieved on: 
Wednesday, October 21, 2020

Our ibuprofen products are effectively used by millions across 40 markets globally and have been available as over-the-counter (OTC) medicines for more than 35 years.

Key Points: 
  • Our ibuprofen products are effectively used by millions across 40 markets globally and have been available as over-the-counter (OTC) medicines for more than 35 years.
  • We welcome any further investigation into the use of ibuprofen or other NSAIDs for the treatment of mild COVID-19 symptoms."
  • GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
  • Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort studyPLoS Med.

Newly Published Preclinical Data on Oragenics, Inc.’s Lantibiotic Compound Demonstrates Tolerability and Compartmentalization to the GI Tract

Retrieved on: 
Monday, May 13, 2019

These data published in TAAP further validate the lantibiotic platform as a potential treatment approach against C.

Key Points: 
  • These data published in TAAP further validate the lantibiotic platform as a potential treatment approach against C.
  • The published study evaluated the tolerability of three doses of OG253 in healthy rats in a one-dose escalation study, followed by a seven-day repeated dose toxicokinetics study.
  • All three doses (6.75, 27 and 108 mg./day) of the compound were well-tolerated with no treatment-related clinical signs.
  • Even at the highest dose, there were no significant toxic effects, and the compound remained compartmentalized to the gastrointestinal tract, as intended.

Lactic Acid Market and Polylactic Acid Market to Reach US$ 3,381.8 Mn and US$ 1,358.1 Mn Respectively by 2023 - TMR

Retrieved on: 
Wednesday, March 13, 2019

In 2014, the global lactic acid market was evaluated around worth of US$1,130.4 Mn and is likely to reach US$3,381.8 Mn by the end of forecast period.

Key Points: 
  • In 2014, the global lactic acid market was evaluated around worth of US$1,130.4 Mn and is likely to reach US$3,381.8 Mn by the end of forecast period.
  • Request a Sample of Global Lactic Acid Market and Polylactic Acid Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_...
    In lactic acid market, the biodegradable plastics segment bagged the key position in the end-use segment emerged as the dominant end-use segment holding over 35% of entire market in year 2014.
  • The rising use of lactic acid as a key carboxylic acid progressively utilized in the production of biodegradable is catalyzing the global lactic acid market.
  • The report segments the global lactic acid Market and Polylactic acid market as follows:

Lactic Acid Market and Polylactic Acid Market to Reach US$ 3,381.8 Mn and US$ 1,358.1 Mn Respectively by 2023 - TMR

Retrieved on: 
Wednesday, March 13, 2019

In 2014, the global lactic acid market was evaluated around worth of US$1,130.4 Mn and is likely to reach US$3,381.8 Mn by the end of forecast period.

Key Points: 
  • In 2014, the global lactic acid market was evaluated around worth of US$1,130.4 Mn and is likely to reach US$3,381.8 Mn by the end of forecast period.
  • Request a Sample of Global Lactic Acid Market and Polylactic Acid Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_...
    In lactic acid market, the biodegradable plastics segment bagged the key position in the end-use segment emerged as the dominant end-use segment holding over 35% of entire market in year 2014.
  • The rising use of lactic acid as a key carboxylic acid progressively utilized in the production of biodegradable is catalyzing the global lactic acid market.
  • The report segments the global lactic acid Market and Polylactic acid market as follows: